Kinetin Riboside-5''-monophosphorodichloridate is an intermediate used in the synthesis of Kinetin Riboside-5''-monophosphate (K570020), which can be used in pharmacological activity and therapeutic use for structure-related anticancer activity of natural cytokinins. Along with other adenosine derivatives, it can also be used in biological study for manufacture of pharmaceutical formulations for treatment against various parasites, mycoplasmas, other indications and other infections and human immunodeficiency virus inhibition.
